E-cigarette, or vaping, product use associated lung injury (EVALI): case series and diagnostic approach

The Lancet Respiratory Medicine

Volumn 7, Issue 12, 2019, Pages 1017-1026

  Kalininskiy, Aleksandr ^a   Bach, Christina T ^a,c   Nacca, Nicholas E ^b,c,d   Ginsberg, Gary ^e,f   Marraffa, Jeanna ^d,g   Navarette, Kristen A ^e,f,h   McGraw, Matthew D ^a,c   Croft, Daniel P ^a,c  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c STRONG MEMORIAL HOSPITAL   (United States)

^d Upstate New York Poison Center   (United States)

^e NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^f Center for Cell Biology and Cancer Research   (United States)

^g State University of New York Upstate Medical University: College of Medicine   (United States)

^h ALBANY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; TETRAHYDROCANNABINOL; DRONABINOL;

ADULT; ALGORITHM; ARTICLE; CASE STUDY; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DIAGNOSTIC TEST; DISEASE SEVERITY; DYSPNEA; E CIGARETTE OR VAPING PRODUCT USE ASSOCIATED LUNG INJURY; ENVIRONMENTAL HEALTH; FEEDBACK SYSTEM; FEMALE; FEVER; FOLLOW UP; HEART DISEASE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HUMAN CELL; HYPOXEMIA; IMAGE DISPLAY; INTENSIVE CARE UNIT; INTERVIEW; LABORATORY TEST; LUNG DISEASE; LUNG INJURY; MALE; MEDICAL EXPERT; MEDICAL RECORD REVIEW; NEW YORK; OUTPATIENT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SPIROMETRY; SYMPTOM; SYMPTOMATOLOGY; THORAX RADIOGRAPHY; TOXICOLOGY; UNIVERSITY HOSPITAL; VAPING; VOMITING; ADVERSE EVENT; DIAGNOSTIC IMAGING; ELECTRONIC CIGARETTE; LENGTH OF STAY; PATHOPHYSIOLOGY; URINE; X-RAY COMPUTED TOMOGRAPHY; YOUNG ADULT;

ADRENAL CORTEX HORMONES; ADULT; DRONABINOL; ELECTRONIC NICOTINE DELIVERY SYSTEMS; FEMALE; HUMANS; LENGTH OF STAY; LUNG INJURY; MALE; NEW YORK; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; VAPING; YOUNG ADULT;

EID: 85075315189     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(19)30415-1     Document Type: Article

References (36)

1. WHO. Global report on trends in prevalence of tobacco smoking 2000–25. 2018, World Health Organization, Geneva.
2. Cullen, KA, Ambrose, BK, Gentzke, AS, Apelberg, BJ, Jamal, A, King, BA, Notes from the field: use of electronic cigarettes and any tobacco product among middle and high school students—United States, 2011–2018. MMWR Morb Mortal Wkly Rep, 67, 2018, 1276.
3. Breitbarth, AK, Morgan, J, Jones, AL, E-cigarettes—an unintended illicit drug delivery system. Drug Alcohol Depend 192 (2018), 98–111.
4. Trivers, KF, Phillips, E, Gentzke, AS, Tynan, MA, Neff, LJ, Prevalence of cannabis use in electronic cigarettes among US youth. JAMA Pediatr 172 (2018), 1097–1099.
5. Rahman, I, Lamb, T, Muthumalage, T, JUUL e-cigarette and vape pen flavors impose oxidative stress and inflammatory responses in lung epithelial cells and macrophages. 2019, American Thoracic Society May 20,2019 (abstr A4186-A).
6. Raber, JC, Elzinga, S, Kaplan, C, Understanding dabs: contamination concerns of cannabis concentrates and cannabinoid transfer during the act of dabbing. J Toxicol Sci 40 (2015), 797–803.
7. Wester, RC, Maibach, HI, Gruenke, LD, Craig, JC, Benzene levels in ambient air and breath of smokers and non-smokers in urban and pristine environments. J Toxicol Environ Health 18 (1986), 567–573.
8. Huang, J, Duan, Z, Kwok, J, et al. Vaping versus JUULing: how the extraordinary growth and marketing of JUUL transformed the US retail e-cigarette market. Tob Control 28 (2019), 146–151.
9. Khan, MS, Khateeb, F, Akhtar, J, et al. Organizing pneumonia related to electronic cigarette use: a case report and review of literature. Clinical Respir J 12 (2018), 1295–1299.
10. Bonilla, A, Blair, AJ, Alamro, SM, et al. Recurrent spontaneous pneumothoraces and vaping in an 18-year-old man: a case report and review of the literature. J Med Case Rep 13 (2019), 1–6.
11. Jatlaoui, TC, Outbreak of lung injury associated with e-cigarette product use or vaping: information for clinicians. Oct 24, 2019, Centers for Disease Control and Prevention https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html#what-we-know. (Accessed 26 October 2019)
12. Layden, JE, Ghinai, I, Pray, I, et al. Pulmonary illness related to e-cigarette use in Illinois and Wisconsin—preliminary report. N Engl J Med, 2019 published online Sept 6. DOI:10.1056/NEJMoa1911614.
13. Flower, M, Nandakumar, L, Singh, M, Wyld, D, Windsor, M, Fielding, D, Respiratory bronchiolitis-associated interstitial lung disease secondary to electronic nicotine delivery system use confirmed with open lung biopsy. Respirol Case Rep, 5, 2017, e00230.
14. Anderson, RP, Zechar, K, Lung injury from inhaling butane hash oil mimics pneumonia. Respir Med Case Rep 26 (2019), 171–173.
15. Agustin, M, Yamamoto, M, Cabrera, F, Eusebio, R, Diffuse alveolar hemorrhage induced by vaping. Case Rep Pulmonol, 2018, 2018, 9724530.
16. US Food and Drug Administration. Lung illnesses associated with use of vaping products. https://www.fda.gov/news-events/public-health-focus/lung-illnesses-associated-use-vaping-products, 2019. (Accessed 25 October 2019)
17. McGraw, MD, Houser, GH, Galambos, C, Wartchow, EP, Stillwell, PC, Weinman, JP, Marijuana medusa: the many pulmonary faces of marijuana inhalation in adolescent males. Pediatr Pulmonol 53 (2018), 1619–1626.
18. Viswam, D, Trotter, S, Burge, PS, Walters, GI, Respiratory failure caused by lipoid pneumonia from vaping e-cigarettes. BMJ Case Rep, 2018, 2018 bcr-2018–224350.
19. Siegel, DA, Update: interim guidance for health care providers evaluating and caring for patients with suspected e-cigarette, or vaping, product use associated lung injury—United States, October 2019. MMWR Morb Mortal Wkly Rep 68 (2019), 919–927.
20. Caliendo, AM, Gilbert, DN, Ginocchio, CC, et al. Better tests, better care: improved diagnostics for infectious diseases. Clin Infect Dis 57:suppl 3 (2013), S139–S170.
21. Zumla, A, Al-Tawfiq, JA, Enne, VI, et al. Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections—needs, advances, and future prospects. Lancet Infect Dis 14 (2014), 1123–1135.
22. Örtqvist, Å, Kalin, M, Lejdeborn, L, Lundberg, B, Diagnostic fiberoptic bronchoscopy and protected brush culture in patients with community-acquired pneumonia. Chest 97 (1990), 576–582.
23. Wu, Q, Jiang, D, Minor, M, Chu, HW, Electronic cigarette liquid increases inflammation and virus infection in primary human airway epithelial cells. PLoS One, 9, 2014, e108342.
24. Miyashita, L, Suri, R, Dearing, E, et al. E-cigarette vapour enhances pneumococcal adherence to airway epithelial cells. Eur Respir J, 51, 2018, 1701592.
25. Azad, A, 14 young people in two states hospitalized after vaping, health officials say. https://www.cnn.com/2019/08/03/health/vaping-hospitalizations-wisconsin-illinois/index.html?no-st=1568563695, 2019. (Accessed 25 October 2019)
26. Triantafyllou, GA, Tiberio, PJ, Zou, RH, et al. Vaping-associated acute lung injury: a case series. Am J Respir Crit Care Med, 2019 published online Oct 1. DOI:10.1164/rccm.201909-1809LE.
27. Omaiye, EE, Cordova, I, Davis, B, Talbot, P, Counterfeit electronic cigarette products with mislabeled nicotine concentrations. Tob Regul Sci 3 (2017), 347–357.
28. New York State Department of Health. New York State Department of Health announces update on investigation into vaping-associated pulmonary illnesses. https://www.health.ny.gov/press/releases/2019/2019-09-05_vaping.htm, 2019. (Accessed 26 October 2019)
29. Davidson, K BA, Heetderks, P, et al. Outbreak of electronic-cigarette–associated acute lipoid pneumonia—North Carolina, July–August, 2019. https://www.cdc.gov/mmwr/volumes/68/wr/mm6836e1.htm, 2019. (Accessed 25 October 2019)
30. Maddock, SD, Cirulis, MM, Callahan, SJ, et al. Pulmonary lipid-laden macrophages and vaping. N Engl J Med 381 (2019), 1488–1489.
31. Betancourt, SL, Martinez-Jimenez, S, Rossi, SE, Truong, MT, Carrillo, J, Erasmus, JJ, Lipoid pneumonia: spectrum of clinical and radiologic manifestations. Am J Roentgenol 194 (2010), 103–109.
32. Christiani, DC, Vaping-induced lung injury. N Engl J Med, 2019 published online Sept 6. DOI:10.1056/NEJMe1912032.
33. Madison, MC, Landers, CT, Gu, B-H, et al. Electronic cigarettes disrupt lung lipid homeostasis and innate immunity independent of nicotine. J Clin Invest 129 (2019), 4290–4304.
34. Reidel, B, Radicioni, G, Clapp, PW, et al. E-cigarette use causes a unique innate immune response in the lung, involving increased neutrophilic activation and altered mucin secretion. Am J Respir Crit Care Med 197 (2018), 492–501.
35. The National Academies of Sciences, Engineering, Medicine. Public health consequences of e-cigarettes. http://nationalacademies.org/hmd/Reports/2018/public-health-consequences-of-e-cigarettes.aspx, Jan 23, 2018. (Accessed 25 October 2019)
36. Wadgave, U, Nagesh, L, Nicotine replacement therapy: an overview. Int J Health Sci 10 (2016), 425–435.